Amgen shares jump after teasing 'encouraging' weight loss data
(Reuters) - U.S. drugmaker Amgen's shares jumped 13% to $316.26 premarket on Friday as the company teased encouraging data for its experimental obesity drug, igniting investor hopes but leaving Wall Street frustrated over a lack of details. Amgen, ...
May 03, 2024
Biden expands health insurance access for DACA immigrants
By Ted Hesson WASHINGTON (Reuters) - U.S. President Joe Biden's administration will allow certain immigrants illegally brought to the U.S. as children greater access to federally run health insurance, the White House said on Friday, addressing a se...
May 03, 2024
Brazil declares country foot-and-mouth disease-free without vaccination
SAO PAULO (Reuters) - Brazil declared itself on Thursday as free of foot and mouth disease without vaccination, and will request World Organization for Animal Health (WOAH) to recognize that status as it seeks to open more markets for its meat expo...
May 02, 2024
DaVita gains after upbeat quarterly profit prompts annual forecast raise
(Reuters) - DaVita raised its annual profit forecast on Thursday banking on strong demand for its kidney dialysis services, sending its shares up 3.7% in trading after the bell. The healthcare services provider raised the lower end of its 2024 adju...
May 02, 2024
Amgen first-quarter profit dips 1%, revenue rises 22%
By Deena Beasley (Reuters) - Amgen reported a slightly lower first-quarter profit on Thursday, citing higher operating and interest expense from its recent acquisition of rare disease drugmaker Horizon Therapeutics, partially offset by double-digit...
May 02, 2024
GSK knew about Zantac cancer risk, attorneys tell jury in first trial
By Diana Novak Jones (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the ...
May 02, 2024
Bird flu outbreak in dairy cows fails to deter US raw milk sellers
By Lisa Baertlein, Julie Steenhuysen and Tom Polansek LOS ANGELES/CHICAGO (Reuters) - U.S. sellers of raw milk appear undeterred by federal health warnings for consumers to avoid drinking unpasteurized milk in light of a bird flu outbreak that has ...
May 02, 2024
Cigna lifts annual profit view on lower medical costs, pharmacy benefit strength
By Bhanvi Satija (Reuters) -Cigna Group raised its annual profit forecast on Thursday, helped by lower-than-expected medical costs and strength in its pharmacy benefit management unit. The health insurer's second forecast raise this year is in sharp co...
May 02, 2024
IQVIA trims full-year revenue forecast on stronger dollar
(Reuters) - Contract research firm IQVIA Holdings lowered its annual revenue forecast on Thursday due to a stronger dollar and reported a quarter-over-quarter fall in a closely-watched metric, sending shares down nearly 4%. The company expects 2024...
May 02, 2024
Digital health startup Transcarent valued at $2.2 billion after latest funding round
(Reuters) - Digital health startup Transcarent notched a valuation of $2.2 billion after its latest fund raise, led by General Catalyst and 7wireVentures, amid signs of a rebound in the funding market. The company said on Thursday it had raised $12...
May 02, 2024
Novo Nordisk: Wegovy, Ozempic prices in US fell in Q1
LONDON (Reuters) - Novo Nordisk has seen the price of its hugely popular weight-loss drug Wegovy and diabetes drug Ozempic fall in the United States as volumes and competition have increased, a senior executive said on Thursday. Wegovy prices in th...
May 02, 2024
Cardinal Health lifts 2024 profit view on demand for costly specialty drugs
(Reuters) - Cardinal Health raised its annual profit forecast on Thursday, betting on strength in its pharmaceutical unit selling costly specialty drugs used to treat complex conditions such as cancer. Drug distributors, including rival Cencora, ha...
May 02, 2024
Baxter raises annual profit forecast on strong demand for medical devices
(Reuters) - Medical device maker Baxter International raised its annual profit forecast and beat quarterly estimates on Thursday, banking on strong demand for its infusion pumps and dialysis products. Investor expectations around the performance of...
May 02, 2024
Zimmer Biomet beats Q1 profit estimates on robust demand for knee, hip devices
(Reuters) - Medtech firm Zimmer Biomet Holdings beat Wall Street estimates for first-quarter profit on Thursday, on the back of robust demand for its devices that are used in knee and hip reconstruction procedures. Zimmer's results extend a strong ...
May 02, 2024
Zoetis beats profit estimates on strong demand for pet products
(Reuters) - Animal healthcare company Zoetis surpassed analysts' expectations for first-quarter profit on Thursday, helped by strong demand for its medicines and vaccines for pets. Zoetis deals with vaccines, medicines and diagnostic solutions for ...
May 02, 2024
Teleflex beats quarterly profit estimates on healthy demand for medical devices
(Reuters) - Teleflex reported a better-than-expected first-quarter profit on Thursday, on the back of strong demand for its medical devices. The Wayne, Pennsylvania-based company also raised the lower end of its 2024 adjusted profit forecast to $13...
May 02, 2024
Novartis to buy radiology specialist Mariana Oncology for $1 billion
(Reuters) - Novartis has entered an agreement to acquire US radiopharmaceutical company Mariana Oncology for $1 billion, the Swiss drug manufacturer said on Thursday. The deal also includes $750 million of potential further payments upon achieving ...
May 02, 2024
Becton Dickinson lifts profit view on strong surgical equipment demand
(Reuters) - Becton Dickinson raised its annual profit forecast and beat second-quarter profit estimates on Thursday, as the group banks on strong demand for its surgical equipment and syringes. Medical technology firms like Becton, Boston Scientifi...
May 02, 2024
Moderna quarterly sales beat expectations but plummet from previous year
By Patrick Wingrove (Reuters) - Moderna on Thursday reported quarterly revenue that beat Wall Street estimates but came in dramatically lower than the previous year when demand for COVID-19 vaccines was higher. Sales of Moderna's COVID-19 shot Spi...
May 02, 2024
Regeneron misses profit estimates on weaker Eylea and Dupixent sales
(Reuters) -U.S. drugmaker Regeneron Pharmaceuticals Inc missed Wall Street estimates for first-quarter profit on Thursday due to softer sales of its blockbuster eye drug Eylea and its eczema treatment, Dupixent. Excluding items, the company reported a ...
May 02, 2024
Cigna sees strong annual profit on lower costs, pharmacy benefit strength
(Reuters) - Health insurer Cigna Group raised its annual profit forecast on Thursday, as lower-than-expected medical costs and strength in its pharmacy benefit management unit helped it beat first-quarter earnings estimates. The company now expects...
May 02, 2024
India widens spices crackdown with nationwide checks on all manufacturers
By Rishika Sadam HYDERABAD (Reuters) - India's food safety regulator said on Thursday it had ordered nationwide testing and inspections at all companies making spice mixes, widening a crackdown on the sector as global regulators investigate contam...
May 02, 2024
Obesity drugmaker Novo Nordisk's Q1 profit beats forecast
LONDON (Reuters) - Novo Nordisk posted on Thursday first-quarter operating profit above analyst forecasts, as the Danish drugmaker races to boost output of its hugely popular weight-loss drug Wegovy and fend off competition from Eli Lilly. (Report...
May 02, 2024
British pharmacies vie for weight-loss patients with drug price cuts
By Ludwig Burger (Reuters) - Online pharmacies and slimming clinics are cutting prices for Wegovy and Mounjaro in Britain just months after the weight-loss drugs were launched there, as initial supply shortages ease. But growing competition between...
May 02, 2024
Bird flu test shows meat supply is safe, USDA says
(Reuters) - The U.S. Department of Agriculture (USDA) said on Wednesday that all the ground beef samples sent to the National Veterinary Services Laboratories (NVSL) for PCR testing, tested negative for H5N1 virus. "NVSL reported that all samples t...
May 02, 2024